Adaptimmune Therapeutics shares owned by Parallel Advisors
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Parallel Advisors
from 13F filings
Historical chart of Parallel Advisors investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Parallel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $33 | 250 | 0.13 |
| 2025-06-30 | $60 | 250 | 0.24 |
| 2025-03-31 | $49 | 250 | 0.20 |
| 2024-12-31 | $135 | 250 | 0.54 |
| 2024-09-30 | $6.8k | 7.2k | 0.95 |
| 2024-06-30 | $244 | 250 | 0.98 |
| 2022-03-31 | $4.0k | 1.9k | 2.16 |
| 2021-12-31 | $3.0k | 812 | 3.69 |
| 2021-09-30 | $3.0k | 715 | 4.20 |
| 2021-06-30 | $3.0k | 715 | 4.20 |
| 2021-03-31 | $4.0k | 715 | 5.59 |
| 2020-12-31 | $5.0k | 905 | 5.52 |
| 2020-09-30 | $6.0k | 715 | 8.39 |
| 2020-06-30 | $7.0k | 715 | 9.79 |
| 2020-03-31 | $2.0k | 1.1k | 1.84 |
| 2019-09-30 | $0 | 0 | 0.00 |
| 2019-06-30 | $998 | 314 | 3.18 |
| 2019-03-31 | $998 | 314 | 3.18 |
| 2018-12-31 | $998 | 314 | 3.18 |